Literature DB >> 26184410

Is your love in vain? On associations between genotypes, drug concentrations and clinical outcomes in pharmacogenomic research.

Per Damkier1.   

Abstract

Mesh:

Year:  2015        PMID: 26184410     DOI: 10.1007/s11096-015-0167-3

Source DB:  PubMed          Journal:  Int J Clin Pharm


× No keyword cloud information.
  15 in total

1.  Opportunities and limitations: the value of pharmacogenetics in clinical practice.

Authors:  Ann K Daly; Ingolf Cascorbi
Journal:  Br J Clin Pharmacol       Date:  2014-04       Impact factor: 4.335

2.  Personalized medicine: Time for one-person trials.

Authors:  Nicholas J Schork
Journal:  Nature       Date:  2015-04-30       Impact factor: 49.962

3.  Seven Questions for Personalized Medicine.

Authors:  Michael J Joyner; Nigel Paneth
Journal:  JAMA       Date:  2015-09-08       Impact factor: 56.272

4.  Precision medicine--personalized, problematic, and promising.

Authors:  J Larry Jameson; Dan L Longo
Journal:  N Engl J Med       Date:  2015-05-27       Impact factor: 91.245

Review 5.  Applications and limitations in translating genomics to clinical practice.

Authors:  Brian Van Ness
Journal:  Transl Res       Date:  2015-05-04       Impact factor: 7.012

6.  Precision medicine: the future or simply politics?

Authors:  Rita Rubin
Journal:  JAMA       Date:  2015-03-17       Impact factor: 56.272

Review 7.  Pharmacogenomic biomarkers for personalized cancer treatment.

Authors:  C Rodríguez-Antona; M Taron
Journal:  J Intern Med       Date:  2015-02       Impact factor: 8.989

8.  A pharmacogenetic versus a clinical algorithm for warfarin dosing.

Authors:  Stephen E Kimmel; Benjamin French; Scott E Kasner; Julie A Johnson; Jeffrey L Anderson; Brian F Gage; Yves D Rosenberg; Charles S Eby; Rosemary A Madigan; Robert B McBane; Sherif Z Abdel-Rahman; Scott M Stevens; Steven Yale; Emile R Mohler; Margaret C Fang; Vinay Shah; Richard B Horenstein; Nita A Limdi; James A S Muldowney; Jaspal Gujral; Patrice Delafontaine; Robert J Desnick; Thomas L Ortel; Henny H Billett; Robert C Pendleton; Nancy L Geller; Jonathan L Halperin; Samuel Z Goldhaber; Michael D Caldwell; Robert M Califf; Jonas H Ellenberg
Journal:  N Engl J Med       Date:  2013-11-19       Impact factor: 91.245

Review 9.  Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers.

Authors:  Henry M Dunnenberger; Kristine R Crews; James M Hoffman; Kelly E Caudle; Ulrich Broeckel; Scott C Howard; Robert J Hunkler; Teri E Klein; William E Evans; Mary V Relling
Journal:  Annu Rev Pharmacol Toxicol       Date:  2014-10-02       Impact factor: 13.820

Review 10.  Biomarkers for personalized oncology: recent advances and future challenges.

Authors:  Madhu Kalia
Journal:  Metabolism       Date:  2014-10-30       Impact factor: 8.694

View more
  1 in total

1.  Making individualized drugs a reality.

Authors:  Huub Schellekens; Mohammed Aldosari; Herre Talsma; Enrico Mastrobattista
Journal:  Nat Biotechnol       Date:  2017-06-05       Impact factor: 54.908

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.